Gary, E.N., Tursi, N.J., Hojecki, C.E. et al. Electroporation and LNP-mediated delivery of plasmid DNA-encoded H5N1 influenza virus hemagglutinin support protection against highly pathogenic avian influenza. npj Vaccines (2025)
Highly pathogenic avian influenzas (HPAIs) is a continuing public health threat. Here, we describe the development of plasmid-encoded H5N1 hemagglutinin antigens representing clades that have caused human zoonoses. Electroporation (EP) delivery of clade 2.3.2.1c HA (pCamb) DNA was immunogenic in mice but only partially protective against clade 2.3.4.b challenge. Homologous challenge resulted in complete protection, suggesting that matched clade antigens are important for protection. Contemporary clade 2.3.4.4b HA (pMich) DNA plasmids supported robust cellular and humoral responses when delivered via EP. Co-immunization with plasmids representing both H5 clades supported high titers of binding and neutralizing antibodies against both antigens and complete protection from clade 2.3.4.4b challenge. We formulated the pMich plasmid DNA in lipid nanoparticles (LNPs). A single dose of pMich DNA-LNP supported long-lived immunity in mice that was protective against challenge at both acute and memory timepoints. These data demonstrate that DNA can support robust anti-HPAI immunity and protection.
See Also:
Latest articles in those days:
- Host Species Contribution to the Spatiotemporal Dynamics of the 2024-2025 H5N1 Epidemic in Italy 17 hours ago
- mRNA-based influenza vaccine expands the B cell response breadth in humans 17 hours ago
- Molecular surveillance and predictive risk modelling of avian influenza virus in wild birds in Egypt 17 hours ago
- Germany as a key transit hub for the emergence and spread of high pathogenicity avian influenza H5 clade 2.3.4.4b reassortants in Europe 2 days ago
- Degradation of ACSL3 by influenza A virus shifts unfolded protein response from antiviral defense to viral evasion 2 days ago
[Go Top] [Close Window]


